Open House Biologic Discount Agreements 2025-18 - Insulin glargin (100 U/ml)
Original notice title
Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2025-18 - Insulin glargin (Wirkstärke: 100 U/ml)
Opportunity Score
Why this score?
Opportunity
40 / 100
Complexity
60 / 100
Risk factors
The procedure is not a public procurement subject to procurement review; disputes go to social courts. Legal recourse i...
No estimated value – potential revenue is unknown. Contract may attract many participants, diluting volume.
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- Supplies contract
- 1 lot
- Duration until Aug 2027
- Execution of a discount agreement (Rabattvertrag) for Insulin glargin (100 U/ml) with participating health insurance funds.
- Supply of the pharmaceutical product under standardized conditions for up to 24 months.
Show full summary
This is an Open-House procedure for pharmaceutical discount agreements (Rabattverträge) on Insulin glargin (100 U/ml) with multiple German statutory health insurance funds led by Techniker Krankenkasse. The procedure is open to all qualified pharmaceutical entrepreneurs who meet the eligibility criteria. The contract term is up to 24 months starting from 1 September 2025 (with a later start for hkk on 1 October 2025) and ending no later than 31 August 2027. No estimated value is provided. The award is based solely on meeting eligibility requirements, not on competition. Electronic submission is not allowed via the portal; contracts must be submitted by email (with qualified electronic signature) or by post.
Risks
The procedure is not a public procurement subject to procurement review; disputes go to social courts. Legal recourse i...
No estimated value – potential revenue is unknown. Contract may attract many participants, diluting volume.
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Must be a pharmaceutical entrepreneur (pharmazeutischer Unternehmer) as defined in § 4 Abs. 18 AMG.
- Must hold a valid marketing authorization for the product in Germany or be entitled to place it on the market under own name.
- Seat must be in Germany, another EU member state, or an EEA state.
Requirements may be incomplete.
Buyer
Location
Hamburg, DEU
Website
Identifier
992-80116-93
Activity
Health
Lots (1)
LOT-0001
Open House Biologic Discount Agreements 2025-18 - Insulin glargin (100 U/ml)
Ziel ist der Abschluss von Arzneimittelrabattverträgen nach § 130a Abs. 8 SGB V zu dem Wirkstoff Insulin glargin (Wirkstärke: 100 U/ml) im Rahmen eines Open-House-Verfahrens. The lot covers nationwide supply of Insulin glargin with a maximum contract duration of 24 months.
Location
Duration
Category
Deadline
Award details
Ziel ist der Abschluss von Arzneimittelrabattverträgen nach § 130a Abs. 8 SGB V zu dem Wirkstoff Insulin glargin (Wirkstärke: 100 U/ml) im Rahmen eines Open-House-Verfahrens.
Value note
Show original TED data
Original lot title
Open-House-Biologika-Rabattverträge 2025-18 - Insulin glargin (Wirkstärke: 100 U/ml)
Original TED description
Ziel ist der Abschluss von Arzneimittelrabattverträgen nach § 130a Abs. 8 SGB V zu dem Wirkstoff Insulin glargin (Wirkstärke: 100 U/ml) im Rahmen eines Open-House-Verfahrens.
Procurement Details
- Publication date
- 09 Jun 2025
- Languages
- German
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 372143-2025
Documents (1)
Similar tenders
Germany – Site preparation work – VE111 Baustelleneinrichtung (119VM514 / Kronsh,SanDstBw,Ersatzneub. ZInstSanBw)
Poland – Advertising and marketing services – Zaplanowanie i realizacja kampanii Ministerstwa Finansów z zakresu działalności resortu finansów
France – Insurance services – Prestations de services d'assurance pour groupement le groupement hospitalier de territoire Yvelines Nord
Finland – Architectural, construction, engineering and inspection services – Tietomallikoordinaattori-, inventointimittaus- ja mallinnuspalvelujen puitejärjestely 2026-2028 (2028-2030)
Greece – Cultural event organisation services – ΛΕΙΤΟΥΡΓΙΑ ΤΟΥ ΘΕΑΤΡΟΥ ΟΛΥΜΠΙΑ ΜΑΡΙΑ ΚΑΛΛΑΣ ΜΕ ΕΞΕΙΔΙΚΕΥΜΕΝΟ ΠΡΟΣΩΠΙΚΟ
Spain – Architectural, construction, engineering and inspection services – Redacción del Proyecto Básico y de Ejecución, Redacción del Estudio de Seguridad y Salud y Dirección de Obra para la construcción del I.E.S. Nº 1 de 12+0 uds. (Fase 1) en la urbanización El Bosque de Pioz (Guadalajara).
Opportunity Score
Why this score?
Opportunity
40 / 100
Complexity
60 / 100
Risk factors
The procedure is not a public procurement subject to procurement review; disputes go to social courts. Legal recourse i...
No estimated value – potential revenue is unknown. Contract may attract many participants, diluting volume.
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications